These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32098299)

  • 1. Manipulating the In Vivo Behaviour of
    Imberti C; Adumeau P; Blower JE; Al Salemee F; Baguña Torres J; Lewis JS; Zeglis BM; Terry SYA; Blower PJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.).
    Ma MT; Cullinane C; Imberti C; Baguña Torres J; Terry SY; Roselt P; Hicks RJ; Blower PJ
    Bioconjug Chem; 2016 Feb; 27(2):309-18. PubMed ID: 26286399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer Scaffold for the Amplification of In Vivo Pretargeting Ligations.
    Cook BE; Membreno R; Zeglis BM
    Bioconjug Chem; 2018 Aug; 29(8):2734-2740. PubMed ID: 29969558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.
    Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS
    Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specific Photoaffinity Bioconjugation for the Creation of
    Delaney S; Nagy Á; Karlström AE; Zeglis BM
    Mol Imaging Biol; 2023 Dec; 25(6):1104-1114. PubMed ID: 37052759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
    Schuhmacher J; Kaul S; Klivényi G; Junkermann H; Magener A; Henze M; Doll J; Haberkorn U; Amelung F; Bastert G
    Cancer Res; 2001 May; 61(9):3712-7. PubMed ID: 11325843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.
    Cusnir R; Imberti C; Hider RC; Blower PJ; Ma MT
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α
    Imberti C; Terry SY; Cullinane C; Clarke F; Cornish GH; Ramakrishnan NK; Roselt P; Cope AP; Hicks RJ; Blower PJ; Ma MT
    Bioconjug Chem; 2017 Feb; 28(2):481-495. PubMed ID: 27966893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and
    Vivier D; Fung K; Rodriguez C; Adumeau P; Ulaner GA; Lewis JS; Sharma SK; Zeglis BM
    Theranostics; 2020; 10(4):1746-1757. PubMed ID: 32042334
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
    Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
    J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.
    Vosjan MJ; Perk LR; Roovers RC; Visser GW; Stigter-van Walsum M; van Bergen En Henegouwen PM; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):753-63. PubMed ID: 21210114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
    Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
    Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the Concept of Multivalency with
    Summer D; Rangger C; Klingler M; Laverman P; Franssen GM; Lechner BE; Orasch T; Haas H; von Guggenberg E; Decristoforo C
    Contrast Media Mol Imaging; 2018; 2018():3171794. PubMed ID: 29849512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.
    Ma MT; Cullinane C; Waldeck K; Roselt P; Hicks RJ; Blower PJ
    EJNMMI Res; 2015 Dec; 5(1):52. PubMed ID: 26452495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms.
    Schmidtke A; Läppchen T; Weinmann C; Bier-Schorr L; Keller M; Kiefer Y; Holland JP; Bartholomä MD
    Inorg Chem; 2017 Aug; 56(15):9097-9110. PubMed ID: 28742337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of New Bifunctional Chelators with Phosphonic Acid Arms for Gallium-68 Based PET Imaging in Melanoma.
    Gai Y; Sun L; Lan X; Zeng D; Xiang G; Ma X
    Bioconjug Chem; 2018 Oct; 29(10):3483-3494. PubMed ID: 30205001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules.
    Westerlund K; Honarvar H; Norrström E; Strand J; Mitran B; Orlova A; Eriksson Karlström A; Tolmachev V
    Mol Pharm; 2016 May; 13(5):1668-78. PubMed ID: 27010700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Young JD; Abbate V; Imberti C; Meszaros LK; Ma MT; Terry SYA; Hider RC; Mullen GE; Blower PJ
    J Nucl Med; 2017 Aug; 58(8):1270-1277. PubMed ID: 28408532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.